Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.01
-19.2%
$0.01
$0.02
$1.94
$351K0.672.58 million shs4,823 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$1.74
-0.6%
$3.16
$1.46
$316.92
$964K0.4490,247 shs61,901 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.08
$0.11
$0.08
$0.50
$861K0.457,975 shs152 shs
NVIVQ
Invivo Therapeutics
$0.37
$0.37
$0.00
$0.00
$1.15M0.4N/AN/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-19.23%-12.13%-2.78%+22.09%-94.06%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-0.57%-10.31%-50.71%-47.75%-99.20%
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%-18.90%-23.49%-42.07%-82.51%
NVIVQ
Invivo Therapeutics
0.00%0.00%0.00%0.00%+36,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.8562 of 5 stars
3.30.00.00.00.60.00.0
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.1652 of 5 stars
0.02.00.00.01.10.00.6
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
NVIVQ
Invivo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIOLASE, Inc. stock logo
BIOL
BIOLASE
2.67
Moderate Buy$1.2011,328.57% Upside
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
NVIVQ
Invivo Therapeutics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$48.83M0.01N/AN/A($0.07) per share-0.15
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$250K3.86N/AN/A$934.50 per share0.00
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.03N/AN/A$0.57 per share0.14
NVIVQ
Invivo Therapeutics
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-$20.63M-$14.94N/AN/A-41.65%-1,782.73%-55.31%5/12/2025 (Estimated)
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$9.95M-$772.37N/AN/AN/A-155.67%-117.82%5/21/2025 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.82N/AN/A-8.35%-41.81%-9.56%5/7/2025 (Estimated)
NVIVQ
Invivo Therapeutics
-$10.49MN/A0.00N/AN/AN/AN/AN/A

Latest BIOL, NVIVQ, DYNT, and BJDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/31/2025Q4 2024
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$36.00-$112.37-$76.37-$112.37N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
NVIVQ
Invivo Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/A
0.71
0.36
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
6.26
6.26
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
NVIVQ
Invivo Therapeutics
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
8.79%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
NVIVQ
Invivo Therapeutics
12.32%

Insider Ownership

CompanyInsider Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.27%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.37%
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
NVIVQ
Invivo Therapeutics
2.45%
CompanyEmployeesShares OutstandingFree FloatOptionable
BIOLASE, Inc. stock logo
BIOL
BIOLASE
16033.41 million33.32 millionNot Optionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
9554,000551,000Not Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
NVIVQ
Invivo Therapeutics
63.11 million3.03 millionN/A

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOLASE stock logo

BIOLASE NASDAQ:BIOL

$0.01 0.00 (-19.23%)
As of 05/5/2025

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$1.74 -0.01 (-0.57%)
Closing price 05/6/2025 03:58 PM Eastern
Extended Trading
$1.76 +0.02 (+1.44%)
As of 05/6/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.08 0.00 (0.00%)
As of 05/6/2025 10:33 AM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Invivo Therapeutics NASDAQ:NVIVQ

$0.37 0.00 (0.00%)
As of 07/26/2024

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.